PHARMAPRESS CO Tablet Ref.[51196] Active ingredients: Enalapril Hydrochlorothiazide

Source: Health Products Regulatory Authority (ZA)  Revision Year: 2023  Publisher: PHARMACARE LIMITED, Healthcare Park, Woodlands Drive, Woodmead 2191

Product name and form

PHARMAPRESS CO 20,0/12,5 mg tablets.

Pharmaceutical Form

Tablets.

A round, white to off-white biconvex tablet.

Qualitative and quantitative composition

Each tablet of PHARMAPRESS CO contains 20,0 mg of enalapril maleate and 12,5 mg of hydrochlorothiazide.

Contains sugar: Lactose monohydrate 130,50 mg.

For full list of excipients, see section 6.1.

Active Ingredient Description
Enalapril

Enalapril is hydrolysed via hepatic CES 1 to the active metabolite enalaprilat, which acts as an ACE inhibitor. ACE is a peptidyl dipeptidase which catalyses the conversion of angiotensin I to the vasoconstrictor substance angiotensin II and hence inhibition of ACE results in decreased plasma angiotensin II. This also leads to increased plasma renin activity and decreased aldosterone secretion. The mechanism of action of enalapril is therefore primarily via the suppression of the RAAS. However, ACE is identical to kininase II, and so enalapril may also exert its effects by blocking the degradation of bradykinin, a potent vasodepressor peptide.

Hydrochlorothiazide

Hydrochlorothiazide is a diuretic with antihypertensive properties. It acts by inhibiting the renal tubular re-absorption of sodium and chloride ions, which are excreted with an accompanying volume of water. Potassium excretion is also promoted.

List of Excipients

Lactose monohydrate
Maize starch
Zinc stearate

Pack sizes and marketing

28 or 30 tablets are packed in a matt silver polyamide, aluminium and polyvinylchloride film sealed with an aluminium foil backing. The blister strip is packed into an outer cardboard carton.

Marketing authorization holder

PHARMACARE LIMITED, Healthcare Park, Woodlands Drive, Woodmead 2191

Marketing authorization dates and numbers

34/7.1.3/0190

Date of first authorization: 20 April 2001

Drugs

Drug Countries
PHARMAPRESS CO South Africa

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.